Elevai Labs
ELAB
6 hedge funds and large institutions have $388K invested in Elevai Labs in 2026 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
5,322% more capital invested
Capital invested by funds: $7.16K → $388K (+$381K)
200% more funds holding
Funds holding: 2 → 6 (+4)
11.95% more ownership
Funds ownership: 0.03% → 11.97% (+12%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$405K |
| 2 |
Morgan Stanley
New York
|
+$192K |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
+$190K |
| 4 |
IA
IFP Advisors
Tampa,
Florida
|
+$25.6K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$15.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$26 |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$10 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $189K | +$405K | +31,594 | New |
|
|
2
Morgan Stanley
New York
| $89.8K | +$192K | +15,000 | New |
|
|
SSA
3
Schonfeld Strategic Advisors
New York
| $88.7K | +$190K | +14,800 | New |
|
|
IA
4
IFP Advisors
Tampa,
Florida
| $12K | +$25.6K | +2,000 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $7.8K | +$15.8K | +1,231 | +1,734% |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $773 | -$26 | -2 | -2% |
|
|
7
Bank of America
Charlotte,
North Carolina
| – | -$10 | – | – |
|
ELAB Hedge Fund Activity: Q1 2026 in Review
6 of the 8,132 institutional investors tracked by Wall St. Rank reported a position in Elevai Labs (ELAB) for Q1 2026, worth a combined $388K — up 5,322% from $7.16K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ELAB positions and 0 closed out — a net gain of 4 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $405K. The largest seller was Tower Research Capital (TRC), cutting an estimated $26.
- 6 institutional investors held Elevai Labs (ELAB) as of Q1 2026, up from 2 in Q4 2025.
- Funds reported $388K of Elevai Labs stock for Q1 2026, up 5,322% quarter-over-quarter.
- 4 funds opened new Elevai Labs positions in Q1 2026 and 0 closed out, a net change of +4 holders.
- The largest Elevai Labs buyer in Q1 2026 was Jane Street, an estimated $405K added.
- The largest Elevai Labs seller in Q1 2026 was Tower Research Capital (TRC), an estimated $26 sold.
Based on aggregated 13F filings for Q1 2026.